Looking at the filing, I need to extract substantive financial and operational content. The filing text provided is primarily the cover page, table of contents, and forward-looking statements section. Let me check if there is substantive disclosure content beyond boilerplate to work with. The cover page confirms: PACS Group, Inc., NYSE:PACS, Form 10-Q for the quarterly period ended September 30, 2026, filed with 158,723,533 shares outstanding as of October 30, 2026. The company is classified as an accelerated filer, incorporated in Delaware, headquartered in Salt Lake City, Utah. The forward-looking statements section references several company-specific items including: the Amended and Restated Credit Facility, SEC investigation, restatement of prior periods, material weaknesses in internal control over financial reporting, self-insurance liabilities, geographic concentration in California, and healthcare/skilled nursing operations. This content is substantive enough to work with.

PACS Group, Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission on November 3, 2026, covering the quarterly period ended September 30, 2026, disclosing share count, filer status, and a range of company-specific risk and operational matters.

Key Highlights

  • Share count: As of October 30, 2026, PACS Group reported 158,723,533 shares of common stock, par value $0.001 per share, outstanding.
  • Filer classification: The company is classified as an accelerated filer and is not a smaller reporting company or emerging growth company, according to the filing.
  • Restatement disclosed: The filing references "the restatement of prior periods and related impacts" as a subject of forward-looking statements and risk disclosure.
  • SEC investigation referenced: The company disclosed the existence of an SEC investigation, noting forward-looking statements address "the scope, timing, costs, and potential impacts" of that investigation.
  • Material weakness flagged: The filing identifies material weaknesses in internal control over financial reporting as a risk factor, noting potential impairment to "timely and accurate reporting."
  • Amended credit facility: The company referenced its "Amended and Restated Credit Facility, amendments, waivers, and forbearance arrangements" in connection with its liquidity and capital resources disclosures.
  • Geographic concentration: The filing notes concentration of facilities in California as a specific risk, citing "vulnerability to local economic downturns, regulatory changes or natural disasters."

PACS Group's Third-Quarter 2026 Filing: Key Disclosures on Controls, Investigations, and Operations

PACS Group, Inc. (NYSE:PACS), a Delaware-incorporated healthcare facility operator headquartered at 90 S. 400 W., Suite 700, Salt Lake City, Utah 84101, submitted its quarterly report for the period ended September 30, 2026. The filing covers the three and nine months ended September 30, 2026, and includes condensed consolidated financial statements, management's discussion and analysis, and disclosures on legal proceedings and risk factors, according to the table of contents included in the submission.

The company disclosed several ongoing matters that it characterizes as subjects of forward-looking statements. These include the status of an SEC investigation, the restatement of prior periods, and the condition of its internal controls. According to the filing, material weaknesses in internal control over financial reporting could "impair timely and accurate reporting, reduce investor confidence, subject us to penalties, and affect the value of our common stock." The company also referenced forbearance arrangements in connection with its Amended and Restated Credit Facility, indicating active negotiations or agreements with lenders during the period covered.

PACS Group operates in the skilled nursing and healthcare facility sector, and the filing identifies reimbursement from third-party payors, patient acuity mix, and payor mix as factors that "could negatively impact our revenue and results of operations." The company also flagged risks tied to labor shortages for nurses and nurse assistants, potential regulatory audits of billing and care delivery, and litigation common to the healthcare industry. Geographic concentration of facilities, particularly in California, is cited as increasing exposure to local regulatory and economic developments. The filing notes the company leases most of its facilities, adding lease termination and extension risk to its disclosed risk profile.

What Was Disclosed

PACS Group's Form 10-Q for the quarter ended September 30, 2026, disclosed 158,723,533 shares outstanding as of October 30, 2026, an accelerated filer classification, an ongoing SEC investigation, prior-period restatements, material weaknesses in internal controls, and forbearance arrangements under its credit facility.